Edwards Lifesciences has received CE mark approval for its Cardioband Tricuspid Valve Reconstruction System, making it the first commercially available transcatheter therapy to treat tricuspid valve heart disease.

A measure of global longitudinal strain (GLS) was far more predictive of mortality than left ventricular ejection fraction (LVEF) in a study of 4,172 patients with acute heart failure, demonstrating its potential as a new standard technique.

With the opioid epidemic in full swing and many intravenous drug users likely to relapse and require even more challenging and expensive treatment, physicians are left to grapple with what to do about repeat cases of infective endocarditis.

Living a healthy lifestyle during adulthood could prolong life expectancy at age 50 by 14 years for women and more than 12 years for men, according to new research published April 30 in the American Heart Association’s Circulation journal.

A healthy diet is a cornerstone to preventing cardiovascular disease, but many healthcare providers receive insufficient nutrition education and training, according to a new scientific advisory released by the American Heart Association.

A late-breaking study presented at SCAI 2018 demonstrated that patients who stay in the hospital for more than 72 hours after transcatheter aortic valve replacement (TAVR) are more likely to die in the following year than those with earlier discharges.

Operators trained in the hybrid approach to PCI of chronic total occlusions (CTOs) demonstrated technical and procedural success rates of 87 percent and 85 percent, respectively, in a multicenter international trial.

A post-approval study of Abbott’s MitraClip device showed positive one-year results for the first 2,000 patients entered into the national Transcatheter Valve Therapy registry, according to late-breaking science presented April 26 at SCAI 2018 in San Diego.